Synchronous Primary Cancers of the Breast and Cervix: Planning Multidisciplinary Primary Treatment
- 1 February 2000
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in American Journal of Clinical Oncology
- Vol. 23 (1), 99-103
- https://doi.org/10.1097/00000421-200002000-00026
Abstract
Multiple metachronous primary malignancies are becoming increasingly frequent; however, multiple synchronous primary malignancies are still unusual. We report the case of a 61-year-old woman with synchronous stage IIIB ductal carcinoma of the left breast and FIGO stage IB2 squamous cell carcinoma of the cervix. The patient was treated initially every 4 weeks with a 24-h intravenous infusion of paclitaxel (175 mg/m2) followed by a 1-h infusion of carboplatin (area under the curve of 5 mg/ml x min) with concurrent irradiation of the pelvis. Significant toxic reactions including nausea, vomiting, and diarrhea required hospitalization or outpatient intravenous fluids and antiemetics. After four cycles of chemotherapy, the breast cancer was in complete clinical remission, and the patient underwent a modified radical mastectomy with axillary lymph node dissection. Pathologic findings revealed a few microscopic foci of residual infiltrating ductal carcinoma exhibiting a marked treatment effect; none of the 14 axillary lymph nodes removed showed evidence of metastatic tumor. A near-complete pathologic response of the breast cancer and a complete clinical response of the cervical cancer were obtained. Adjuvant chemotherapy for the breast cancer was then initiated, followed by radiation and hormonal therapy.Keywords
This publication has 14 references indexed in Scilit:
- Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical CancerThe New England Journal of Medicine, 1999
- The TaxoidsDrugs, 1998
- Paclitaxel by 3-H infusion and carboplatin in anthracycline-resistant advanced breast cancer. A phase II study conducted by the hellenic cooperative oncology groupEuropean Journal of Cancer, 1997
- Paclitaxel and docetaxel in breast and ovarian cancerDrug and Therapeutics Bulletin, 1997
- Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study.Journal of Clinical Oncology, 1996
- Multiple primaries among gynecologic malignanciesGynecologic Oncology, 1984
- A case of triple primary gynecological malignancyGynecologic Oncology, 1984
- Multiple primary cancers of breast and cervix uteri: an epidemiological approach to analysisBritish Journal of Cancer, 1981
- Multiple primary malignant neoplasms.Historical perspectivesCancer, 1977
- Multiple malignant neoplasms in the charity hospital of louisiana tumor registryCancer, 1977